nucleolytic activity
Recently Published Documents


TOTAL DOCUMENTS

30
(FIVE YEARS 0)

H-INDEX

11
(FIVE YEARS 0)

Author(s):  
Carsten Lüdtke ◽  
Sebastian Sobottka ◽  
Julian Heinrich ◽  
Phil Liebing ◽  
Stefanie Wedepohl ◽  
...  

2019 ◽  
Vol 20 (23) ◽  
pp. 6041 ◽  
Author(s):  
Sergey Brezgin ◽  
Anastasiya Kostyusheva ◽  
Dmitry Kostyushev ◽  
Vladimir Chulanov

The gene editing tool CRISPR-Cas has become the foundation for developing numerous molecular systems used in research and, increasingly, in medical practice. In particular, Cas proteins devoid of nucleolytic activity (dead Cas proteins; dCas) can be used to deliver functional cargo to programmed sites in the genome. In this review, we describe current CRISPR systems used for developing different dCas-based molecular approaches and summarize their most significant applications. We conclude with comments on the state-of-art in the CRISPR field and future directions.


2017 ◽  
Vol 8 (1) ◽  
Author(s):  
Xianning Lai ◽  
Ronan Broderick ◽  
Valérie Bergoglio ◽  
Jutta Zimmer ◽  
Sophie Badie ◽  
...  

AbstractFailure to restart replication forks stalled at genomic regions that are difficult to replicate or contain endogenous DNA lesions is a hallmark of BRCA2 deficiency. The nucleolytic activity of MUS81 endonuclease is required for replication fork restart under replication stress elicited by exogenous treatments. Here we investigate whether MUS81 could similarly facilitate DNA replication in the context of BRCA2 abrogation. Our results demonstrate that replication fork progression in BRCA2-deficient cells requires MUS81. Failure to complete genome replication and defective checkpoint surveillance enables BRCA2-deficient cells to progress through mitosis with under-replicated DNA, which elicits severe chromosome interlinking in anaphase. MUS81 nucleolytic activity is required to activate compensatory DNA synthesis during mitosis and to resolve mitotic interlinks, thus facilitating chromosome segregation. We propose that MUS81 provides a mechanism of replication stress tolerance, which sustains survival of BRCA2-deficient cells and can be exploited therapeutically through development of specific inhibitors of MUS81 nuclease activity.


MedChemComm ◽  
2014 ◽  
Vol 5 (11) ◽  
pp. 1708-1717 ◽  
Author(s):  
P. J. Bindu ◽  
K. M. Mahadevan ◽  
T. R. Ravikumar Naik ◽  
B. G. Harish

A series of simple quinoline–chalcone conjugates have been synthesized and evaluated for their nucleolytic activity. The compounds 3c and 3d exhibited promising DNA binding and DNA photocleavage studies.


2007 ◽  
Vol 101 (4) ◽  
pp. 667-677 ◽  
Author(s):  
Wei Jiang ◽  
Yingchun Han ◽  
Qunhui Pan ◽  
Tao Shen ◽  
Changlin Liu

Sign in / Sign up

Export Citation Format

Share Document